Rocephin and Zemuron drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Rocephin (ceftriaxone sodium) and Zemuron (rocuronium bromide). Common drug interactions include hypertension among females and cardiac disorder among males.
The phase IV clinical study analyzes what interactions people have when they take Rocephin and Zemuron. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.
What is Rocephin?
Rocephin has active ingredients of ceftriaxone sodium. It is often used in infection. eHealthMe is studying from 15,665 Rocephin users. Check the latest studies of Rocephin.
What is Zemuron?
Zemuron has active ingredients of rocuronium bromide. eHealthMe is studying from 873 Zemuron users. Check the latest studies of Zemuron.
21 people who take Rocephin and Zemuron together, and have interactions are studied.

What are the common drug interactions of Rocephin and Zemuron, by gender? *:
female:
- Hypertension (high blood pressure)
- Hypotension (abnormally low blood pressure)
- Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
- Ischaemic nephropathy (damage to or disease of a kidney from insufficient blood supply)
- Lobar pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung)
- Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Muscle haemorrhage (bleeding in muscle)
- Peptic ulcer
- Peripheral embolism (sudden interruption of blood flow to an organ or body part)
male:
- Cardiac disorder
- Abdominal pain
- Dizziness
- Dysphagia (a condition in which swallowing is difficult or painful)
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Fatigue (feeling of tiredness)
- Haemorrhage subcutaneous (bleeding from skin)
- Hypertension (high blood pressure)
- Lip swelling
- Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
What are the common drug interactions of Rocephin and Zemuron, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Hypertension (high blood pressure)
10-19:
- Bone marrow failure
- Bradycardia (abnormally slow heart action)
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Cytokine storm (over-protective immune response that can actually be fatal)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Haematuria (presence of blood in urine)
- Hyperkalaemia (damage to or disease of the kidney)
- Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
- Hypocalcaemia (levels of calcium in blood serum are abnormally low)
- Hypotension (abnormally low blood pressure)
20-29:
n/a
30-39:
n/a
40-49:
- Abdominal pain
- Arthralgia (joint pain)
- Back pain
- Blood pressure decreased
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Cardiac disorder
- Chest discomfort
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Dizziness
- Dysphagia (a condition in which swallowing is difficult or painful)
50-59:
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Aspartate aminotransferase increased
- Cardiac arrest
- Thermal burn (burn by heat)
- Transaminases increased
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Haematochezia (passage of stools containing blood)
- Respiratory failure (inadequate gas exchange by the respiratory system)
60+:
- Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
- Decreased appetite
- Blood pressure fluctuation
- Bronchial hyperreactivity
- Candidiasis (candidiasis or thrush is a fungal infection)
- Cardiac disorder
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Clostridium difficile sepsis (infection(pus formation) of colon by clostridium difficile bacteria)
- Death
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
What are the existing conditions these people have? *
- Hypotension (abnormally low blood pressure): 5 people, 23.81%
- Pneumonia: 4 people, 19.05%
- Asthma: 3 people, 14.29%
- Respiratory Tract Oedema (swelling of respiratory tract due to excess fluid collection in tissue): 3 people, 14.29%
- Pain: 3 people, 14.29%
- Multiple Myeloma (cancer of the plasma cells): 3 people, 14.29%
- Constipation: 3 people, 14.29%
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 14.29%
- Headache (pain in head): 3 people, 14.29%
- Type 2 Diabetes: 2 people, 9.52%
* Approximation only. Some reports may have incomplete information.
Do you take Rocephin and Zemuron?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Rocephin and Zemuron:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rocephin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Zemuron:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rocephin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zemuron and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on ceftriaxone sodium and rocuronium bromide (the active ingredients of Rocephin and Zemuron, respectively), and Rocephin and Zemuron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Famotidine and Low Blood Platelet Count for Girls aged 10-19 - 5 seconds ago
- Famotidine and Low Platelet Count for Girls aged 10-19 - 5 seconds ago
- Famotidine and Platelet Count Decreased for Girls aged 10-19 - 6 seconds ago
- Famotidine and Thin Blood for Girls aged 10-19 - 6 seconds ago
- Famotidine and Thrombocytopenia for Girls aged 10-19 - 7 seconds ago
- Pepcid and Constipation for Women aged 30-39 - 12 seconds ago
- Pepcid and Constipation Aggravated for Women aged 30-39 - 12 seconds ago
- Pepcid and Stool Softener for Women aged 30-39 - 13 seconds ago
- Pepcid and Stool Softener Needs for Women aged 30-39 - 13 seconds ago
- Pepcid and Irregularity Of Bowels for Women aged 30-39 - 14 seconds ago